SKBNF yields 35.71% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, SKBNF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SKBNF + PFE for your $10,000?
Shikun & Binui Ltd., together with its subsidiaries, engages in the infrastructure and construction, real estate development, concessions, energy, and other businesses in Israel and internationally. It engages in building and maintaining infrastructure projects, including government and public facilities, educational and cultural institutions, medical facilities, courthouses, etc.; and development, construction, and operation of power generation facilities using photovoltaic (PV) systems, natural gas, thermo-solar technology, and wind and hydro facilities. The company also undertakes roads, highways, bridges, and water and wastewater treatment plants projects; and digging of tunnels and underpasses, and other works. In addition, it develops residential and commercial units; and rents properties, such as student dormitories, office buildings, and commercial spaces. The company was formerly known as Housing and Construction Holding Company Ltd. and changed its name to Shikun & Binui Ltd. in March 2009. The company was founded in 1920 and is headquartered in Airport City, Israel.
Full SKBNF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.